N/A
Average AnalystN/A
Top AnalystVery Bearish
Stock Target AdvisorN/A
Average UserEUR 6.94
+0.13 (+1.88%)
EUR 7.05M
0.01M
EUR 0.00
Based on the Global X Genomics & Biotechnology UCITS ETF USD Acc stock forecast from 0 analysts, the average analyst target price for Global X Genomics & Biotechnology UCITS ETF USD Acc is not available over the next 12 months. Global X Genomics & Biotechnology UCITS ETF USD Acc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Global X Genomics & Biotechnology UCITS ETF USD Acc is Very Bearish, which is based on 0 positive signals and 3 negative signals. At the last closing, Global X Genomics & Biotechnology UCITS ETF USD Acc’s stock price was EUR 6.94. Global X Genomics & Biotechnology UCITS ETF USD Acc’s stock price has changed by +1.17% over the past week, +1.82% over the past month and -1.28% over the last year.
Target Price Action | Rating Action | Analyst | Rating | Price | Date |
---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.